Mubritinib

CAS 366017-09-6

Also known as: Mubritinib TAK 165

Mubritinib (TAK-165) is a potent Neu (HER2) and Cdc2 p34 inhibitor with IC50 of 6 nM and 0.2μM, respectively. TAK 165

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: mubritinib-366017-09-6
Payment & Shipping Terms Supply Capacity
Payment Terms: T/T, WU Production Capacity: 1000kg/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Mubritinib

CAS 366017-09-6

Mubritinib (TAK-165) is a potent Neu (HER2) and Cdc2 p34 inhibitor with IC50 of 6 nM and 0.2μM, respectively. TAK 165

alsoinhibits p33cdk2 and p33cdk5. TAK 165 displays > 4000-fold selectivity over EGFR, FGFR, PDGFR, JAK1 and Src.

TAK 165 exhibits potent antiproliferative effects in Neu-overexpressing cancer cell lines (IC50 = 5 nM in BT474 breast

cancer cells) and significantly inhibits bladder, breast and prostate cancer xenograft growth.

We can customize according to customer's requirement

if you have any question pls mail us or call us.

CAS Number 366017-09-6
Place of Origin Shandong,China (Mainland)
Brand MOSINTER
Formula C25H23F3N4O2
Mol. mass 468.47 g/mol
Boiling point 620.9°C at 760 mmHg
Request a quote

Send an inquiry for Mubritinib

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP